Expression, purification and characterization of inactive and active forms of ERK2 from insect expression system

Kelly Yan1, Hanne Merritt2, Kenneth Crawford1

  • 1Protein Sciences, Novartis Institutes for BioMedical Research, Inc., 5300 Chiron Way, Emeryville, CA 94608, USA.

Insights

Researchers developed an efficient insect expression system to produce inactive and active forms of Extracellular signal-regulated kinase 2 (ERK2). This system significantly improves yield and supports cancer drug discovery efforts.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Extracellular signal-regulated kinase 2 (ERK2) is a key regulator of cellular processes and a significant target for cancer therapy.
  • Existing methods for producing ERK2 have limitations in yield and homogeneity.

Purpose of the Study:

  • To establish a robust insect expression system for generating both inactive and active forms of ERK2.
  • To support high-throughput biochemical screening and small molecule drug discovery for cancer treatment.

Main Methods:

  • Expression and purification of unphosphorylated (inactive) ERK2 in an insect system.
  • In vivo co-expression of ERK2 with constitutively active MEK1 to generate active ERK2.
  • Biochemical characterization of both ERK2 forms, including phosphorylation site confirmation (T185, Y187).

Main Results:

  • Achieved 100% homogeneous inactive ERK2 with a 20-fold yield improvement over bacterial systems.
  • Successfully generated active ERK2, confirmed to be doubly phosphorylated at T185 and Y187.
  • Both inactive and active ERK2 forms demonstrated robust kinase activity.

Conclusions:

  • The developed insect expression system provides a superior method for producing high-quality inactive and active ERK2.
  • These ERK2 reagents are crucial for advancing high-throughput screening and structural drug discovery in cancer research.

Related Concept Videos